DEMAND FDA REFORM NOW!

Smoke-free nicotine products, such as nicotine pouches, can help adults transition away from cigarettes. Unfortunately, regulatory roadblocks at the U.S. Food and Drug Administration’s (FDA) Center for Tobacco Products (CTP) are preventing better options from reaching more legal-age adult smokers.

Please answer the questions below to generate your customized letter for your lawmaker.

Why do you believe reforming CTP is important, especially considering that CTP's apathy is delaying or impeding adults who smoke from moving away from cigarettes to smoke-free alternatives?

1/4

Your answers will be used to generate with AI assistance a customized letter to your lawmakers for your review and approval.

How have smoke-free options, including nicotine pouches, helped you or someone you know transition away from cigarettes?

2/4

Your answers will be used to generate with AI assistance a customized letter to your lawmakers for your review and approval.

What are the consequences from your perspective of not reforming CTP, especially given the regulatory roadblocks are limiting access to smoke-free nicotine products for legal-age adults seeking to move away from cigarettes?

3/4

Your answers will be used to generate with AI assistance a customized letter to your lawmakers for your review and approval.

If you had 30 seconds with your Congressman or Senator, what would you want them to know about this issue?

4/4

Your answers will be used to generate with AI assistance a customized letter to your lawmakers for your review and approval.

Dear [Lawmaker],

I am reaching out to emphasize the urgent need for reform at the U.S. Food and Drug Administration’s (FDA) Center for Tobacco Products (CTP).

The agency’s failure to meet Congressionally required deadlines and its lack of transparency are hurting millions of adults. I believe this is important because $q1: these failures are standing in the way of efforts to help adults who smoke transition to smoke-free options:.

As an adult who has seen firsthand the importance of smoke-free options $q2::, we must hold the CTP accountable and demand that the agency reset its approach to authorizing smoke-free nicotine product applications. The CTP must act with urgency, make science-based decisions, and eliminate bureaucratic obstacles. If this reform doesn’t happen, $q3: I am worried that fewer adults will be able to use smoke-free options to transition away from cigarettes:.

I urge you to engage the FDA, advocate for meaningful CTP reform, and ensure the new leadership is committed to efficient and fair regulations that benefit public health.

$q4::

Thank you for your attention to this important issue and for your dedication to ensuring the CTP is doing its job.

Sincerely,
______

Prefix

First Name

Last Name

Phone

Address

Zip

Subject Line